P786: THROMBOSIS AND MENINGOCOCCAL INFECTION RATES IN PEGCETACOPLAN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE CLINICAL TRIAL AND POST-MARKETING SETTINGS
Richard Kelly,
Hisakazu Nishimori,
Regina Horneff,
Peter Hillmen,
Jessica Savage,
Mohammed Al-Adhami,
Stacie Lallier,
Gloria Gerber
Affiliations
Richard Kelly
1 St James’s University Hospital, Leeds, United Kingdom
Hisakazu Nishimori
2 Okayama University Hospital, Okayama, Japan
Regina Horneff
3 Swedish Orphan Biovitrum AB, Stockholm, Sweden
Peter Hillmen
4 Apellis Pharmaceuticals, Inc., Waltham, United States
Jessica Savage
4 Apellis Pharmaceuticals, Inc., Waltham, United States
Mohammed Al-Adhami
4 Apellis Pharmaceuticals, Inc., Waltham, United States
Stacie Lallier
4 Apellis Pharmaceuticals, Inc., Waltham, United States
Gloria Gerber
5 Johns Hopkins University School of Medicine, Baltimore, United States